文献速递消化道肿瘤与早癌消化内镜

早期胃癌中根据日本胃癌协会扩大标准与绝对标准比较的淋巴结转移发生率:文献系统评价与Meta分析

The incidence of lymph node metastasis in early gastric cancer according to the expanded criteria in comparison with the absolute criteria of the Japanese Gastric Cancer Association: a systematic review of the literature and meta-analysis.
PubMed 文献 · Gastrointest Endosc · 2017-09-28

该系统评价纳入12项研究共9798例接受胃切除及淋巴结清扫的早期胃癌患者,比较绝对标准与扩大标准下淋巴结转移(LNM)发生率。绝对标准组LNM为0.2%,扩大标准组为0.7%。扩大标准中不同亚组的LNM风险不一,部分亚组较绝对标准仅轻度升高,而某些亚组显著升高。

要点

  • 绝对标准组LNM发生率为0.2%,扩大标准组为0.7%。
  • 分化型黏膜无溃疡病变不论大小LNM风险与绝对标准无显著差异(RR 1.69,P=.37)。
  • 未分化型黏膜≤2 cm及分化型黏膜下浸润<3 cm的LNM风险显著高于绝对标准。

核心结论

  • 将内镜切除适应证扩大至黏膜无溃疡分化型病变不论大小及溃疡性分化型黏膜病变<3 cm,与绝对标准相比LNM风险增加极小,具有合理性。
  • 将适应证扩大至未分化型病变≤2 cm及分化型病变伴轻度黏膜下浸润(T1b)时,鉴于这些患者LNM风险增加,应与手术风险权衡。

研究设计与样本

  • 系统评价与Meta分析,全面检索主要参考文献数据库,纳入接受胃切除及淋巴结清扫的早期胃癌患者研究,采用随机效应模型进行Meta分析。
  • 共纳入12项研究,合计9798例患者。

主要发现

  • 绝对标准组LNM发生率为0.2%,扩大标准组为0.7%。
  • 分化型黏膜溃疡性病变≤3 cm组LNM为2814例中16例(0.57%),RR 3.01;P=.02。
  • 分化型黏膜无溃疡病变不论大小组LNM为3004例中8例(0.27%),RR 1.69;P=.37。
  • 未分化型黏膜病变≤2 cm组LNM为972例中25例(2.6%),RR 6.79;P=.0004。
  • 分化型病变伴轻度黏膜下浸润<3 cm组LNM为315例中8例(2.5%),RR 6.30;P=.004。

关键数值与推荐

  • 绝对标准:无溃疡、分化良好、黏膜病变直径≤2 cm。
  • 扩大标准包括更大、溃疡性、未分化黏膜病变以及伴轻度黏膜下浸润的分化型病变。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Japanese criteria for curative endoscopic resection of early gastric cancer initially included nonulcerated, well-differentiated mucosal lesions ≤2 cm in diameter, known as the absolute criteria. Subsequently, these indications were expanded to include larger, ulcerated, and undifferentiated mucosal lesions as well as differentiated lesions with slight submucosal invasion. Whether patients meeting the expanded criteria can be managed safely without gastrectomy and lymph node dissection has been controversial. The risk of lymph node metastasis (LNM) in patients who met the expanded criteria is a critical factor in determining the best course of management for these patients. METHODS: We comprehensively searched main reference databases for studies that included patients who underwent gastrectomy and lymph node dissection for early gastric cancer. A meta-analysis was conducted by using the random effects model. Relative risk reduction was used to compare the incidence of LNM in patients meeting the absolute criteria as compared with those meeting the expanded criteria. RESULTS: Twelve studies met the inclusion criteria, providing a total of 9798 patients. The incidence of LNM was 0.2% for patients who met the absolute criteria as compared with 0.7% for patients who met the expanded criteria. Analysis of the various components of the expanded criteria was conducted, revealing that the incidence of LNM for differentiated mucosal lesions ≤3 cm with ulceration and for differentiated mucosal lesions without ulceration, irrespective of size, was 16 of 2814 (0.57%), reference range (RR) 3.01; P = .02 and 8 of 3004 (0.27%), RR 1.69; P = .37, respectively, only marginally higher than the risk of LNM associated with the absolute criteria. In contrast, undifferentiated mucosal lesions ≤2 cm and differentiated lesions <3 cm with slight submucosal invasion had a significantly higher incidence of LNM in comparison with the absolute criteria (25/972 [2.6%], RR 6.79; P = .0004 and 8/315 [2.5%], RR 6.30; P = .004, respectively). CONCLUSION: Overall, expanding the indication for endoscopic resection to include mucosal nonulcerated differentiated lesions irrespective of size and differentiated mucosal ulcerated lesions <3 cm is justified with minimal increased risk in comparison to the absolute criteria. However, expanding the indication for undifferentiated lesions ≤2 cm and differentiated lesions with slight submucosal invasion (T1b) should be balanced with the risks of surgery, given the increased risk of LNM in these patients.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Abdelfatah MM, Barakat M, Lee H, et al. The incidence of lymph node metastasis in early gastric cancer according to the expanded criteria in comparison with the absolute criteria of the Japanese Gastric Cancer Association: a systematic review of the literature and meta-analysis. Gastrointest Endosc. 2017. PMID: 28966062. doi:10.1016/j.gie.2017.09.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。